Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Gastfriend

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
JAMA|March 24, 2005
Physician substance abuse and recovery: what does it mean for physicians--and everyone else?David R Gastfriend
Annals of the New York Academy of Sciences|September 20, 2014
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersDavid R Gastfriend
Annals of the New York Academy of Sciences|January 29, 2011
Intramuscular extended-release naltrexone: current evidenceDavid R Gastfriend
The Psychiatric Clinics of North America|September 2, 2022
Thirty Years of TheASAMCriteria: A Report CardDavid R Gastfriend, David Mee-Lee
Journal of Psychiatry & Neuroscience : JPN|September 26, 2002
Olanzapine-induced hyperventilation: case reportS Pirzada Sattar, David R Gastfriend
Journal of Addictive Diseases|July 5, 2005
Reliability of multidimensional substance abuse treatment matching: implementing the ASAM Patient Placement CriteriaSharon L Baker, David R Gastfriend
The Annals of Pharmacotherapy|September 24, 2002
Visual inspection of medications in preventing unexplained relapsesS Pirzada Sattar, David R Gastfriend
Journal of Addictive Diseases|July 5, 2005
The ASAM patient placement criteria: context, concepts and continuing developmentDavid R Gastfriend, David Mee-Lee
The American Journal of Managed Care|July 19, 2011
Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistenceOnur Baser, Mady Chalk, Richard Rawson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 9, 2002
Addiction denial and cognitive dysfunction: a preliminary investigationWilliam Rinn, Nitigna Desai, Harold Rosenblatt, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
JAMA|March 24, 2005
Physician substance abuse and recovery: what does it mean for physicians--and everyone else?David R Gastfriend
Annals of the New York Academy of Sciences|September 20, 2014
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersDavid R Gastfriend
Annals of the New York Academy of Sciences|January 29, 2011
Intramuscular extended-release naltrexone: current evidenceDavid R Gastfriend
The Psychiatric Clinics of North America|September 2, 2022
Thirty Years of TheASAMCriteria: A Report CardDavid R Gastfriend, David Mee-Lee
Journal of Psychiatry & Neuroscience : JPN|September 26, 2002
Olanzapine-induced hyperventilation: case reportS Pirzada Sattar, David R Gastfriend
Journal of Addictive Diseases|July 5, 2005
Reliability of multidimensional substance abuse treatment matching: implementing the ASAM Patient Placement CriteriaSharon L Baker, David R Gastfriend
The Annals of Pharmacotherapy|September 24, 2002
Visual inspection of medications in preventing unexplained relapsesS Pirzada Sattar, David R Gastfriend
Journal of Addictive Diseases|July 5, 2005
The ASAM patient placement criteria: context, concepts and continuing developmentDavid R Gastfriend, David Mee-Lee
The American Journal of Managed Care|July 19, 2011
Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistenceOnur Baser, Mady Chalk, Richard Rawson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 9, 2002
Addiction denial and cognitive dysfunction: a preliminary investigationWilliam Rinn, Nitigna Desai, Harold Rosenblatt, et al.
Pageof 6